PMBS Financials Monday, July 14, 2014 10:12:38 PM
PuraMed BioScience, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 43 693 9 32
Cost of Revenue 95 184 7 14
Gross Profit (53) 509 1 18
Operating Expenses
Research and Development 75 18 59 109
Sales, General and Admin. 1,823 1,789 981 1,162
Non-Recurring Items - - - -
Other 55 51 49 49
Operating Income (2,006) (1,349) (1,087) (1,302)
Income From Continuing Operations
Add'l Income/Expense Items (28) 103 (77) -
Earnings Before Interest and Tax (2,034) (1,246) (1,164) (1,301)
Interest Expense 529 476 325 180
Earnings Before Tax (2,563) (1,721) (1,489) (1,481)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,657) (1,721) (1,489) (1,481)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,563) (1,721) (1,489) (1,481)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,563) (1,721) (1,489) (1,481)